Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
Clinical trial NCT00800683 · COMPLETED
Trial details
- NCT number
- NCT00800683
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.